Location History:
- New York, NY (US) (2012 - 2017)
- Waterville, OH (US) (2022)
Company Filing History:
4 out of 512 
1 out of 559 
Years Active: 2012-2025
Title: The Innovative Contributions of Michelle Adams
Introduction
Michelle Adams is a prominent inventor based in New York, NY, known for her significant contributions to the field of immunology. With a total of five patents to her name, she has made remarkable strides in the development of adjuvants for vaccines. Her work focuses on enhancing the efficacy and safety of immunological treatments.
Latest Patents
One of her latest patents is titled "Triterpene saponins, methods of synthesis and uses thereof." This invention relates to triterpene glycoside saponin-derived adjuvants, including the synthesis methods and their applications. The patent highlights QS-7, a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin currently favored in anticancer and antiviral vaccines. The tedious isolation and purification protocols have previously hindered the clinical development of QS-7. However, Michelle's novel semi-synthetic method utilizes a hydrolyzed prosapogenin mixture to synthesize QS-7, QS-21, and related analogs, greatly facilitating access to these compounds for preclinical and clinical evaluation.
Career Highlights
Throughout her career, Michelle has worked with esteemed institutions such as the Sloan Kettering Institute for Cancer Research and the Memorial Sloan Kettering Cancer Center. Her research has significantly impacted the field of cancer treatment and vaccine development, showcasing her